Clinical Trial Detail

NCT ID NCT02952248
Title A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

urinary bladder cancer

triple-receptor negative breast cancer

ovarian cancer

Advanced Solid Tumor

stomach cancer

renal cell carcinoma

lung non-small cell carcinoma

melanoma

Therapies

BI 754091

Age Groups: senior adult

No variant requirements are available.